Valeant Pharmaceuticals International (VRX) said its wholly owned subsidiary, Valeant Canada Limited, has agreed to acquire Laboratoire Dr. Renaud, a cosmeceutical company located in Canada for approximately C$23 million. The transaction is expected to be accretive in 2010.
Further, as part of the transaction, Valeant will also enter into a lease for a 45 thousand square foot facility that includes a manufacturing plant completed in 2007 specializing in topical formulations.
The transaction is expected to occur before the end of the year.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.